www.fdanews.com/articles/127338-teva-pharma-announces-launch-of-generic-valtrex
Teva Pharma Announces Launch of Generic Valtrex
May 25, 2010
Teva Pharmaceutical Industries Tuesday announced FDA approval and commercial launch of its generic version of GlaxoSmithKline’s antiviral product, Valtrex (valacyclovir hydrochloride) Tablets 500 mg and 1 g.
StreetInsider
StreetInsider